Switching to aromatase inhibitor (AI) after tamoxifen in premenopausal patients with chemotherapy-induced amenorrhea (CIA) after early breast cancer treatment.
J. A. Perez-Fidalgo
Research Funding - Pfizer
Other Remuneration - Pfizer
M. J. Miranda
No relevant relationships to disclose
B. Bermejo
No relevant relationships to disclose
V. Pons
No relevant relationships to disclose
S. Rosello
No relevant relationships to disclose
E. Garcia-Garre
No relevant relationships to disclose
C. Guzman
Employment or Leadership Position - Pfizer
A. Lluch
Honoraria - Novartis; Pfizer
Research Funding - Pfizer